Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
esomeprazole benta
- Development stage
- Unknown
- Lead developer
- Benta Lyon
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Esomeprazole Benta is a branded generic formulation of esomeprazole, a proton pump inhibitor (PPI) developed and marketed by Benta Lyon. As the S-enantiomer of omeprazole, esomeprazole provides potent and long-lasting reduction of gastric acid secretion by irreversibly inhibiting the H+/K+-ATPase enzyme system (the proton pump) in the gastric parietal cells. It is approved for the treatment of various acid-related gastrointestinal disorders, including gastroesophageal reflux disease (GERD), erosive esophagitis, peptic and duodenal ulcers, and Zollinger-Ellison syndrome. It is also used in combination with antibiotics for the eradication of *Helicobacter pylori*. The drug is typically administered orally in a delayed-release formulation to ensure stability in the acidic environment of the stomach.
- Brand names
- Esomeprazole BentaEsoméprazole Benta
- Other names
- Esoméprazole Benta 20mgEsoméprazole Benta 40mgesomeprazole
02
Targets
ATP4A (Potassium–transporting ATPase alpha chain 1)
Beyond the preview
Go deeper on esomeprazole benta.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on esomeprazole benta.